• Robust, comprehensive endpoint assessments, with up to 15,000 metrics per scan utilizing CT and Xenon MRI biomarkers to measure changes in lung structure and function. VIDA’s platform supports ...
In addition to the DTA Fibrosis Score, VIDA’s ILD offering enables the following trial services: • Enhanced eligibility assessments, supported by novel, patented visualizations, including Tomographic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback